The global Hemapheresis market is anticipated to grow at a CAGR of around 6.8% during the forecast period (2021-2027). The growth of the hemapheresis market is mainly driven due to the increasing mergers and acquisitions, and partnership collaborations among major players to further expand their business and product pipeline. For instance, in February 2021, Cerus Corp and Shandong Zhongbaokang Medical Implements Co. Ltd. (ZBK) came into a joint venture (JV) to develop and obtain regulatory approval to manufacture and commercialize the INTERCEPT Blood System for platelets and red blood cells in China. Moreover, in January 2021, Haemonetics Corp. completed the acquisition of privately-held Cardiva Medical, Inc. for $475 million at closing through a definitive agreement. The acquisition comprises the VASCADE vascular closure system of Haemonetics Corp., along with its all assets. Through this acquisition, the company aimed to expand and diversifies hospital offerings in the large and growing interventional cardiology and electrophysiology markets.
To Request a Sample of our Report on Hemapheresis Market: https://www.omrglobal.com/request-sample/hemapheresis-market
In September 2019, Baxter International Inc. announced the acquisition of Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies. The acquisition was done for $190 million. By acquiring Cheetah Medical, the company aimed to improve clinical outcomes with an established patient monitoring technology. Similarly, in October 2019, Asahi Kasei Medical has completed the acquisition of Virusure Forschung und Entwicklung GmbH (ViruSure), an Austrian provider of biosafety testing services. Through this acquisition, Asahi Kasei Medical expanded its bioprocess business, for biotherapeutics such as plasma derivatives and biopharmaceuticals.
The increasing government support in form of grants for further R&D in hemapheresis devices is also boosting the market growth. For instance, in April 2021, Baxter International Inc. received R&D grant funding of €1.5 million from the German Federal Ministry of Education and Research. The grant will aid Baxter to create a new technology platform for further enhancing its ability to target selective removal of pathogenic substances during blood purification therapies.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Technology
· By Product
· By Procedure
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Asahi Kasei Medical Co., Ltd., Baxter International Inc., Cerus Corp, Fresenius Medical Care AG & Co. KGaA., Haemonetics Corp, Kaneka Corp, Kawasumi Laboratories, Inc., among others.
Key questions addressed by the report
· What is the market growth rate?
· Which segment and region dominate the market in the base year?
· Which segment and region will project the fastest growth in the market?
· How has COVID-19 impacted the market?
· Deviation from the pre-COVID-19 forecast
· Most affected region and segment
· Who is the leader in the market?
· How are players addressing challenges to sustain growth?
· Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full Report of Hemapheresis Market is Available at: https://www.omrglobal.com/industry-reports/hemapheresis-market
Global Hemapheresis Market Report Segment
By Technology
· Centrifugation
· Membrane Separation
· Selective Adsorption
By Product
· Hemapheresis Devices
· Hemapheresis Disposables
By Procedure
· Photopheresis
· Plasmapheresis
· Plateletpheresis
· Leukapheresis
· Erythrocytapheresis
· Others
By Application
· Hematology
· Neurology
· Renal Disease
· Others (Autoimmune Disorder)
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
